JZJiqing Zheng

Jiqing Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiqing Zheng has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioinformatic analysis and clinical diagnostic value of hsa_circ_0004099 in acute ischemic stroke

    by Jiqing Zheng, Shuiming Luo, Yaobin Long

    This study investigates the expression and effect of hsa_circ_0004099 in acute ischemic stroke (AIS). We conducted a case-controlled study that included 40 patients with AIS within 24 hours and 40 healthy subjects during the same period as a control group. Differentially expressed circular RNAs (circRNAs) were obtained using GEO2R, and the expression of hsa_circ_0004099 was verified using RT-PCR. Correlation analysis of the National Institutes of Health Stroke Scale (NIHSS) disease severity score and ischemic time with hsa_circ_0004099 expression levels was also performed. The receiver operating characteristic (ROC) curve of hsa_circ_0004099 was constructed, and bioinformatic analysis of hsa_circ_0004099 was performed. NIHSS scores negatively correlated with hsa_circ_0004099 levels (P<0.001, r = -0.7053), whereas infarct time was negatively correlated with hsa_circ_0004099 levels (P<0.001, r = -0.5130); hsa_circ_0004099 could benefit clinical diagnosis (area under the curve [AUC]: 0.923 [95% confidence interval [CI]: 0.8680–0.9904]). Kyoto encyclopedia of genes and genomes (KEGG) analysis showed that hsa_circ_0004099 was enriched in several cancer pathways, which were collectively enriched in four genes namely TCF7L2, NRAS, CTNNB1, and KRAS. Eight core proteins were screened using a protein-protein interaction (PPI) network namely SMAD4, HIF1A, CTNNB1, CDKN1B, CDK6, FOXO3, KRAS, and NRAS. hsa_circ_0004099 is a potential clinical diagnostic marker. In addition, the possible role of hsa_circ_0004099 in the pathogenesis of AIS was analyzed using bioinformatics, which provided a new potential molecular target for AIS treatment.


  • Open Access

    Meta analysis of the diagnostic efficacy of long non-coding RNA in ischemic stroke

    by Jiqing Zheng, Yaobin Long, Yun Liu

    Objective To evaluate the diagnostic efficacy of long non-coding RNA (lncRNA) for acute ischemic stroke (IS) by Meta analysis. Methods This research had obtained a registration number in PROSPERO (CRD 42021283867). The articles of lncRNA diagnosis of IS in PubMed, Web of Science, Cochrane, CBM, China National Knowledge Network, VIP and Wanfang were searched systematically. The papers was evaluated using the QUADAS-2 scale and a bias risk chart – RevMan5.3. Then, threshold effect, non-threshold effect, combined diagnostic efficacy and subgroup analysis of the articles were analyzed by Meta-DISC 1.4. Finally, the summary receiver operating characteristic (SROC) curve was drawn, sensitivity and publication bias were analyzed by stata16. Results This paper covers eleven studies, including 1717 patients with IS and 1652 healthy subjects. The combined sensitivity of lncRNA diagnosis of IS was 0.70 (95%: 0.69~0.72), specificity was 0.71 (CI95%: 0.69~0.72), the positive likelihood ratio was 2.84 (CI95%: 2.25~3.59), the negative likelihood ratio was 0.39 (CI95%: 0.33~0.46), the diagnostic odds ratio was 7.69 (5.2~11.37) and the area under the curve (AUC) was 80%. Subgroup analysis found that among tissue sources, serum samples had the highest comprehensive diagnostic efficiency, up to 88.5%, and the comprehensive diagnostic efficiency within 24 hours was higher than that within 24 to 72 hours, up to 82.6%. In addition, low expression was slightly higher than high expression, reaching 79.8%. Conclusion There is a high diagnosing efficiency shown in IncRNA, which could be expected to become a predictive tool for IS in the future

  • Open Access

    Differential Expression and Biological Analysis of circRNA in Acute Ischemic Stroke

    by Ji Qing Zheng, Yun Liu, Yaobin Long, Shijie Liang, Chengsen Lin, Mingwei He, Guanglin Yang

    Objective: The study aimed to analyze the function and signal pathway of target genes by bioinformatics software, and then explore the possible role of circRNA molecules in regulating the pathogenesis of AIS so as to provide new potential molecular targets for AIS therapy.Methods: The study searched the circRNA gene array of AIS from the Gene Expression Omnibus and selected the upregulated and downregulated TOP 10 circRNAs to predict the miRNA binding sites of circRNA, which was then intersected with the differentially expressed miRNAs(DEMs) by miRNA gene array. Furthermore, the downstream target genes of miRNA were predicted jointly by three websites and constructed the ceRNA regulatory network, Database for Annotation Visualization and Integrated Discovery function enrichment analysis and protein–protein interaction analysis by the target genes. Results: miR-337-3p and miR-383 were the binding sites of hsa_circ_0004183, and miR-338-3p and miR-140-3p were the binding sites of hsa_circ_0051778 and hsa_circ_0092342, respectively, in addition, the four miRNAs were closely related to AIS. Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that MAPK signaling pathway, PI3K-Akt signaling pathway, P53 signaling pathway, and erbB signaling pathway were upregulated and downregulated pathways. The MCODE plug-in of Cytoscape was used to screen out a set of the most significant core networks, 21 key protein components, 7 of which were closely related to the occurrence and development of AIS. Conclusions: These findings aim to provide reference for the study of the pathogenesis of AIS by circRNA and broaden the idea of treatment.